Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

An Open Label Study of GBT440 to Evaluate the Effect on Oxygenation in Healthy Subjects at Rest and Maximal Exercise Under Hypoxic Conditions

Next Previous
Trial Profile

An Open Label Study of GBT440 to Evaluate the Effect on Oxygenation in Healthy Subjects at Rest and Maximal Exercise Under Hypoxic Conditions

Status: Discontinued
Phase of Trial: Phase I

Latest Information Update: 25 Jun 2018

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Voxelotor (Primary)
  • Indications Hypoxia; Idiopathic pulmonary fibrosis; Sickle cell anaemia
  • Focus Proof of concept; Therapeutic Use
  • Acronyms Basecamp Study
  • Sponsors Global Blood Therapeutics

    • Most Recent Events

    • 23 May 2018 Results investigating the effect of GBT440, an allosteric modulator of hemoglobin, on hypoxic exercise in healthy subjectspresented at the 114th International Conference of the American Thoracic Society
    • 23 May 2018 Results investigating the effect of GBT440, an allosteric modulator of hemoglobin, on hypoxic exercise in healthy subjectspresented at the 114th International Conference of the American Thoracic Society
    • 07 May 2018 According to a company media release, results from this study will be preasented at the upcoming American Thoracic Society Conference 2018
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Legal
Back to top